Literature DB >> 20152909

Life-long increase of substantia nigra hyperechogenicity in transcranial sonography.

Johann Hagenah1, Inke R König, Jürgen Sperner, Lucas Wessel, Günter Seidel, Kelly Condefer, Rachel Saunders-Pullman, Christine Klein, Norbert Brüggemann.   

Abstract

Transcranial ultrasound of the substantia nigra (SN) shows a distinct hyperechogenicity in the majority of patients with Parkinson's disease. Recent studies indicate a larger area of hyperechogenicity in elderly healthy adult subjects. The present study aimed to determine the size of the SN hyperechogenicity and of the mesencephalic brainstem in children and adults without evidence of movement disorders. The areas of echogenicity in the substantia nigra (aSN) and the area of the ipsilateral midbrain (aMid) were assessed in 121 healthy infants and children as well as in 64 healthy adults. Furthermore, the ratio of aSN and aMid was calculated (S/M ratio). We found a positive correlation between age and aSN and between age and the S/M ratio. The values for aSN and S/M ratio were smaller in infants and children compared to healthy adults (aSNmax 0.06+/-0.05 cm2 vs. 0.13+/-0.08 cm2). The aSN and S/M ratio grew with increasing age in an almost linear progression. The increase of SN hyperechogenicity over time suggests that the biological process underlying this ultrasound finding may be more dynamic and possibly progressive than previously thought. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20152909     DOI: 10.1016/j.neuroimage.2010.01.112

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  13 in total

Review 1.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

2.  Basal ganglia hyperechogenicity does not distinguish between patients with primary dystonia and healthy individuals.

Authors:  Johann Hagenah; Inke R König; Charlotte Kötter; Günter Seidel; Christine Klein; Norbert Brüggemann
Journal:  J Neurol       Date:  2010-11-02       Impact factor: 4.849

Review 3.  Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.

Authors:  Andrea Pilotto; Rezzak Yilmaz; Daniela Berg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 4.  Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2010-09-10       Impact factor: 3.575

Review 5.  [Sonography of the parenchyma in Parkinson's disease].

Authors:  J Hagenah; G Seidel
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

6.  Echogenicity of basal ganglia structures in different Huntington's disease phenotypes.

Authors:  Carsten Saft; Rainer Hoffmann; Katrin Strassburger-Krogias; Thomas Lücke; Saskia H Meves; Gisa Ellrichmann; Christos Krogias
Journal:  J Neural Transm (Vienna)       Date:  2014-12-13       Impact factor: 3.575

7.  Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease.

Authors:  M J Barrett; J Hagenah; V Dhawan; S Peng; K Stanley; D Raymond; A Deik; S J Gross; N Schreiber-Agus; A Mirelman; K Marder; L J Ozelius; D Eidelberg; S B Bressman; R Saunders-Pullman
Journal:  Parkinsonism Relat Disord       Date:  2012-10-10       Impact factor: 4.891

8.  Clinical, genetic, and brain sonographic features related to Parkinson's disease in Gaucher disease.

Authors:  Tobias Böttcher; Arndt Rolfs; Bianca Meyer; Annette Grossmann; Daniela Berg; Peter Kropp; Reiner Benecke; Uwe Walter
Journal:  J Neurol       Date:  2013-06-29       Impact factor: 4.849

9.  Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes.

Authors:  Kristina Laučkaitė; Daiva Rastenytė; Danguolė Šurkienė; Antanas Vaitkus; Andrius Sakalauskas; Arūnas Lukoševičius; Rymantė Gleiznienė
Journal:  BMC Neurol       Date:  2012-03-08       Impact factor: 2.474

10.  Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study.

Authors:  Angela E P Bouwmans; Albert F G Leentjens; Werner H Mess; Wim E J Weber
Journal:  Parkinsons Dis       Date:  2016-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.